BIOA logo

BioAge Labs Inc.

BIOA
Healthcare|Biotechnology|US
$5.34
-0.20 (-3.61%)
DCF Value
$8.93
Tangible Book / Share
$7.55
Cash / Share
$6.18
Next Earnings Report
Mar 23, 2027
EPS est. -$0.70 · Revenue est. $175.0K
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Mar 24, 2026 (S-3ASR). Possible dilution.

Upcoming Data Readouts (2)

Nov 2026
Est. completion
P2Obesity and Cardiovascular Risk
A Phase 2 Study to Evaluate the Pharmacodynamics, Safety and Tolerability of BGE-102 in Participants With Obesity and Cardiovascular Risk Factors
NCT07656727n=160
Nov 2027
Est. completion
P2Diabetic Macular Edema (DME)
A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
NCT07812090n=180

Recent Press Releases

BioAge Labs Reports Third Quarter 2026 Financial Results and Provides Business Updates
Nov 5, 2026 · GlobeNewsWire
Deep Origin Announces Multi-Target AI-Driven Drug Discovery Collaboration with BioAge Labs; Validated Hits Confirmed against First Target
Oct 14, 2026 · GlobeNewsWire
BioAge Labs to Present at Upcoming Investor Conferences
Sep 25, 2026 · GlobeNewsWire
BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema
Sep 8, 2026 · GlobeNewsWire
BioAge Labs to Present at Upcoming Investor Conferences
Sep 2, 2026 · GlobeNewsWire

SEC Filings (52)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 202610-QQuarterly reportDocumentIndex
Nov 5, 20268-KMaterial eventDocumentIndex
Oct 2, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 5, 202610-QQuarterly reportDocumentIndex
Aug 5, 20268-KMaterial eventDocumentIndex
Jun 12, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 8, 20268-KMaterial eventDocumentIndex
May 8, 202610-QQuarterly reportDocumentIndex
Apr 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 21, 2026ARSAnnual report to holdersDocumentIndex
Apr 21, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 21, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 24, 2026S-3ASRShelf registrationDocumentIndex
Mar 24, 2026S-8Employee stock planDocumentIndex
Mar 24, 202610-KAnnual reportDocumentIndex
Mar 24, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 22, 20268-KMaterial eventDocumentIndex
Jan 22, 2026424B5Offering prospectusDocumentIndex
Jan 20, 2026424B5Offering prospectusDocumentIndex
Jan 20, 20268-KMaterial eventDocumentIndex
Jan 12, 20268-KMaterial eventDocumentIndex
Dec 4, 20258-KMaterial eventDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Nov 5, 2025S-3/AShelf registrationDocumentIndex
Nov 5, 2025S-3/AShelf registrationDocumentIndex
Oct 2, 2025S-3Shelf registrationDocumentIndex
Oct 2, 2025S-3Shelf registrationDocumentIndex
Aug 14, 2025SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 6, 202510-QQuarterly reportDocumentIndex
Aug 6, 20258-KMaterial eventDocumentIndex
Jun 9, 20258-KMaterial eventDocumentIndex
Jun 4, 20258-KMaterial eventDocumentIndex